Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barker J. D., Jr, de Carle D. J., Anuras S. Chronic excessive acetaminophen use and liver damage. Ann Intern Med. 1977 Sep;87(3):299–301. doi: 10.7326/0003-4819-87-3-299. [DOI] [PubMed] [Google Scholar]
- Bolanowska W., Gessner T. Drug interactions: inhibition of acetaminophen glucuronidation by drugs. J Pharmacol Exp Ther. 1978 Jul;206(1):233–238. [PubMed] [Google Scholar]
- Cummings A. J., King M. L., Martin B. K. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother. 1967 Feb;29(2):150–157. doi: 10.1111/j.1476-5381.1967.tb01948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Douglas A. P., Savage R. L., Rawlins M. D. Paracetamol (acetaminophen) kinetics in patients with Gilber's syndrome. Eur J Clin Pharmacol. 1978 May 31;13(3):209–212. doi: 10.1007/BF00609984. [DOI] [PubMed] [Google Scholar]
- Dybing E. Inhibition of acetaminophen glucuronidation by oxazepam. Biochem Pharmacol. 1976 Jun 15;25(12):1421–1425. doi: 10.1016/0006-2952(76)90113-1. [DOI] [PubMed] [Google Scholar]
- Gugler R., von Unruh G. E. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet. 1980 Jan-Feb;5(1):67–83. doi: 10.2165/00003088-198005010-00002. [DOI] [PubMed] [Google Scholar]
- James O., Lesna M., Roberts S. H., Pulman L., Douglas A. P., Smith P. A., Watson A. J. Liver damage after paracetamol overdose. Comparison of liver-function tests, fasting serum bile acids, and liver histology. Lancet. 1975 Sep 27;2(7935):579–581. doi: 10.1016/s0140-6736(75)90170-1. [DOI] [PubMed] [Google Scholar]
- Johnson G. K., Tolman K. G. Chronic liver disease and acetaminophen. Ann Intern Med. 1977 Sep;87(3):302–304. doi: 10.7326/0003-4819-87-3-302. [DOI] [PubMed] [Google Scholar]
- Levy G., Yamada H. Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. J Pharm Sci. 1971 Feb;60(2):215–221. doi: 10.1002/jps.2600600212. [DOI] [PubMed] [Google Scholar]
- Madan P. L. Acetaminophen toxicity. J Clin Pharmacol. 1977 Oct;17(10 Pt 1):555–560. doi: 10.1177/009127007701701002. [DOI] [PubMed] [Google Scholar]
- Perucca E., Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol. 1979 Feb;7(2):201–206. doi: 10.1111/j.1365-2125.1979.tb00922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg D. M., Meyer A. A., Manning I. H., Jr, Neelon F. A. Acetaminophen and hepatic dysfunction in infectious mononucleosis. South Med J. 1977 Jun;70(6):660–661. doi: 10.1097/00007611-197706000-00007. [DOI] [PubMed] [Google Scholar]
- Shively C. A., Vesell E. S. Temporal variations in acetaminophen and phenacetin half-life in man. Clin Pharmacol Ther. 1975 Oct;18(4):413–424. doi: 10.1002/cpt1975184413. [DOI] [PubMed] [Google Scholar]
- Suchy F. J., Balistreri W. F., Buchino J. J., Sondheimer J. M., Bates S. R., Kearns G. L., Stull J. D., Bove K. E. Acute hepatic failure associated with the use of sodium valproate. N Engl J Med. 1979 Apr 26;300(17):962–966. doi: 10.1056/NEJM197904263001706. [DOI] [PubMed] [Google Scholar]
- Sussman N. M., McLain L. W., Jr A direct hepatotoxic effect of valproic acid. JAMA. 1979 Sep 14;242(11):1173–1174. [PubMed] [Google Scholar]
- Triggs E. J., Nation R. L., Long A., Ashley J. J. Pharmacokinetics in the elderly. Eur J Clin Pharmacol. 1975;8(1):55–62. doi: 10.1007/BF00616415. [DOI] [PubMed] [Google Scholar]
- Willmore L. J., Wilder B. J., Bruni J., Villarreal H. J. Effect of valproic acid on hepatic function. Neurology. 1978 Sep;28(9 Pt 1):961–964. doi: 10.1212/wnl.28.9.961. [DOI] [PubMed] [Google Scholar]